Product Images Eplerenone

This text provides the results of a study on Eplerenone, a medication used to treat high blood pressure and heart failure. The graph shows the cumulative incidence of an outcome (not specified in the text) over time for patients who took Eplerenone versus those who took a placebo. The results suggest that patients who took Eplerenone had a lower incidence of the outcome compared to those who took a placebo, with a statistically significant difference (p=0.008) and a relative risk (RR) of 0.85 (95% confidence interval, 0.75-0.96). The table shows the number of patients at risk over the course of the trial for each treatment group.*

The text describes a figure (Figure 2) that shows the hazard ratios of all-cause mortality by various subgroups, including age, gender, race, diabetes, hypertension, Killip class, creatinine clearance, baseline ACE inhibitors, beta-blockers, digoxin, and diuretics. The figure includes a graph displaying the hazard ratios with a range from 0.0 to 1.0 and confidence intervals. The total number of events and patients for each group is also provided.*

This is a figure depicting the Eplerenone Dose Response in Hypertension studies. It shows the reduction in SBP (mmHg) with different doses of Eplerenone. The x-axis represents the dose of Eplerenone (in mg/day) and the y-axis represents the placebo-subtracted adjusted mean change from baseline. The data is from two different studies - Study1QD and Study2QD, and one study with a dose of Eplerenone administered two times a day (BID).*

The text describes a figure labeled as "Eplerenone Dose Response-Trough Cuff DBP in Hypertension Studies". The figure shows different dose levels of Eplerenone (measured in mg/day) on the y-axis and the placebo-subtracted adjusted mean change from baseline on the x-axis. The different dose levels are marked as 0, 10, 20, 50, 100, 150 and 200. The figure represents two different studies, Study 1 and Study 2, with three different dosing regimens, QD, BID, and QD+D. It is not possible to decipher the exact values or units of the placebo-subtracted adjusted mean change from the figure.*

This is a label of a pharmaceutical product named Greenstone. The brand is distributed by a company called Greenstone LLC located in Peapack, NJ.*

This is a description for eplerenone tablets with a dosage of 25mg. The tablets are distributed by Greenstone LLC and come in a bottle of 30 tablets. It is recommended to store them at a temperature between 15-30°C (59-86°F). For more information on usage, see the prescribing information.*

This text seems to be a collection of medication information that includes drug name, dosage, and manufacturer details. It also contains a few codes that might be used for inventory purposes. However, since the text is fragmented and has many mistakes, it's challenging to interpret it correctly. Therefore, a meaningful description cannot be generated.*

This text is a label for a medication called Eplerenone. It contains 30 tablets, each of which contains 50mg of Eplerenone. The recommended storage temperature is at 25°C (77°F), and it can go on excursions to 15-30°C (59-86°F) [se0. USP Controlled Room Temperature]. For dosage and more details, one needs to see the prescribing information. It is distributed by Greenstone LLC, located in Peapack, NJ 07977, USA. The product code is NDC 59762-1720-1.*